Company: IMG
Filing Date: 2025-11-07
Form Type: 10-Q/A
Source: 0001493152-25-021258
Chunk: 46

Company: CIMG Inc.
Filing Date: 2025-11-07
Form: 10-Q/A
Chunk 46
---
ISK FACTORS

In addition to the other information set forth in this Form 10-Q, you should carefully consider the risk factors discussed in Part I, Item 1A of our Form 10-K, which could affect our business, financial condition, or operating results. The risks we describe in our periodic reports are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, or operating results. For the quarter ended June 30, 2025, the Company is not aware of any specific new and additional risk factors that were not previously disclosed.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) Subsequent to the quarter ended June 30, 2025, the Company completed the following unregistered issuances of its equity securities:

| ● | On                                                                                                                                      
 August 21, 2025, the Company entered into a Convertible Note Purchase Agreement with certain non-U.S. investors, providing for the      
 sale of convertible promissory notes with an aggregate principal amount of $4 million. The notes bear interest at 7% per annum, mature  
 on August 31, 2026, and are convertible into shares of our Common Stock at $0.24 per share. Holders of the convertible notes each       
 converted their notes into 8,333,333 shares of Common Stock, issued on September 9 and October 30, 2025, respectively, for a total      
 of 16,666,666 shares of Common Stock.                                                                                                   |
| ● | On                                                                                                                                      
 September 2, 2025, the Company also closed a private offering of 220,000,000 shares of Common Stock to non-U.S. investors under a       
 Securities Purchase Agreement dated August 25, 2025, for aggregate cash consideration of $55 million (at $0.25 per share). The first    
 148,100,000 shares were issued upon closing, and the remaining 71,900,000 shares were issued on October 29, 2025, following shareholder 
 approval.                                                                                                                               |
| ● | On                                                                                                                                      
 October 22, 2025, holders of warrants previously issued on January 16, 2025 exercised their warrants in full at $0.39 per share,        
 and the Company issued 25,641,023 shares of Common Stock on October 30,